Tony Berberabe, MPH

The Senate is expected to consider and vote on a bill passed by the House on March 27 that includes language to patch the sustainable growth rate (SGR) formula for 12 months and delay ICD-10 implementation until at least October 1, 2015

Provider-based research networks (PBRNs) make clinical trials available to community-based practices.

It looks like trouble continues for a bill that would delay payment cuts to physicians who treat Medicare patients for one year

Practice managers who need to understand the ins and outs of Medicare's resource-based relative value scale (RBRVS) can purchase an updated physician guide from the American Medical Association.

A physician's confidence level in his genomic knowledge plays a significant role in attitudes towards genomic tests, especially in tests that look for changes in DNA that are taken from patients' tumor samples

Founded in 1987, Gilead Sciences made a name for itself in 1996, when it launched Vistide, a treatment for cytomegalovirus retinitis in patients with AIDS.

Small practices face all the difficulties of health IT implementation without the benefit of big budgets and numerous staff to diffuse the burdens, according to EHRIntelligence.com.

Patients were no more likely to switch away from lower-tiered physicians than higher-tiered physicians within their health plan, especially if the physician was considered the patient's personal doctor

Efforts to evaluate cancer survivorship programs are a daunting task according to a technical brief issued by the Agency for Healthcare Research and Quality.

After months of wrangling, a call for a vote by House Majority Leader Eric Cantor on an amended version of the Sustainable Growth Rate (SGR) Repeal and Medicare Provider Payment Modernization Act of 2014 (H.R. 4015).

Converting from ICD-9 to ICD-10 will result in information and financial losses to providers, report researchers from the University of Illinois at Chicago

Evidence that demonstrates how best to implement newer value-based purchasing (VBP) programs like accountable care organizations (ACOs) and bundled payments is lacking

The US cancer care system is faced with increasing cuts to Medicare payments, the prospect of a dramatic increase in the number of patients with cancer, and proportionately fewer oncology specialists to treat them.

More oncology practices are looking to advanced practice nurses and other non-physician providers to meet the needs of their cancer patients.

New research suggests that spending on anticancer agents is moderating, going against national trends that suggest an uptick in the US prescription drug expenditures this year.

With the adoption of a patient engagement initiative, Gwinnett Medical Center in Atlanta was able to improve the billing experience for 86% of patients surveyed.

Repealing the sustainable growth rate (SGR) formula, a mechanism Congress enacted in 1997 to limit Medicare costs, is going to leave taxpayers with a bill of $60 billion from 2014 through 2019, and a total of $138 billion through 2024.

Bavituximab, Peregrine Pharmaceuticals' lead clinical immunotherapeutic candidate, received Fast Track designation from the FDA to kick off 2014.

Bucking a trend reported for many years, new compensation data suggest the gap between what primary care physicians are paid and what medical and surgical specialists are paid is decreasing.

Hospitals and medical centers that provide chemotherapy infusion services to their cancer patients on an outpatient basis generally get paid more than oncologists and hematologists who provide the same services in a private office.

Improvements in quality of care and reductions in hospitalizations were minimal

More and more solo practices are facing a transformation that is neither small nor simple in the current accountable care environment.

Results from the final report of the 2013 Healthcare Information and Management Systems Society (HIMSS) Security Survey suggest that physician practices and health care organizations such as hospitals view their own staff members as the greatest source of patient information and confidentiality security breaches.

Galena Biopharma is looking to expand its presence in the oncology field by developing and acquiring targeted cancer agents.

The Centers for Medicare & Medicaid Services (CMS) is caving to pressure from the American Hospital Association, the American Medical Association, and the Medical Group Management Association (MGMA) to conduct far more extensive end-to-end testing to assure proper adjudication and payment of claims as the October 1 deadline for the ICD-10 transition looms

Vemurafenib (Zelboraf), a BRAF inhibitor approved to treat melanoma, induced a complete clinical remission in a patient with hairy cell leukemia.

Traditionally, palliative care for patients with cancer is geared towards end-of-life measures, but a new study from the Princess Margaret Cancer Center in Toronto suggests patients who receive palliative care earlier in their cancer therapy report improved quality of life and greater satisfaction.

Providing access to health information technology and health information exchanges isn't always enough to avoid ordering duplicative tests

High-tech eyewear could soon help surgeons remove tumors from patients with breast cancer or melanoma by allowing them to see the margins of tumors more accurately when a dye is used to fluoresce a tumor's borders.

To reduce the costs of cancer, community oncologists increase the use of evidence-based treatments, standardize care with pathways, transition away from fee-for-service, and change communication with patients about reasonable end-of-life care.